Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Umbrella Alt Text Close
  • ASH Clinical News
  • ASH News Daily
  • ASH-SAP
  • Blood Journals
    • Blood
    • Blood Advances
    • Blood Global Hematology
    • Blood Immunology & Cellular Therapy
    • Blood Neoplasia
    • Blood Red Cells & Iron
    • Blood Vessels, Thrombosis & Hemostasis
  • Hematology
  • The Hematologist
  • International
    • Blood Chinese Edition
    • Blood Italian Edition
    • Blood Latin America Edition
    • Blood Spanish Edition
  • ASH
    • ASH Home
    • Research
    • Education
    • Advocacy
    • Meetings
    • Publications
    • ASH Store
Cart
User Tools Dropdown
Cart
Sign In
Search Dropdown Menu
header search
    Search
    Blood
    Toggle MenuMenu
    • Issues
      • Current Issue
      • All Issues
    • First edition
    • Abstracts
      • 2024 Annual Meeting
      • 2024 Late Breaking
      • 2023 Annual Meeting
      • 2023 Late Breaking
      • 2022 Annual Meeting
      • 2022 Late Breaking
      • 2021 Annual Meeting
      • 2020 Annual Meeting
      • 2020 Late Breaking
      • All Meeting Abstracts
    • Collections
      • Collections
      • Special Collections
      • Blood Podcast
      • Multimedia
      • Alerts
    • Author Center
      • Submit
      • Author Guide
      • Style Guide
      • Why Submit to Blood?
    • About
      • About Blood
      • Editorial Board
      • Publications Staff
      • Subscriptions
      • Public Access
      • Copyright
      • Alerts
      • Blood Classifieds
    Skip Nav Destination
    Update search
    Querybuilder input 1
    Filter
    • Title
    • Author
    • Full Text
    • Abstract
    • Keyword
    • DOI
    Querybuilder input 2
    Filter
    • Title
    • Author
    • Full Text
    • Abstract
    • Keyword
    • DOI
    Querybuilder input 3
    Filter
    • Title
    • Author
    • Full Text
    • Abstract
    • Keyword
    • DOI
    Querybuilder input 4
    Filter
    • Title
    • Author
    • Full Text
    • Abstract
    • Keyword
    • DOI
    Querybuilder input 5
    Filter
    • Title
    • Author
    • Full Text
    • Abstract
    • Keyword
    • DOI
    Querybuilder input 6
    Filter
    • Title
    • Author
    • Full Text
    • Abstract
    • Keyword
    • DOI

    NARROW

    Publications
    Filter by publications
    Format
    Filter by format
    Article Type
    Filter by article-type
    Topics
    Filter by topics
    Date
    Filter by date
    Apply
    Availability
    Availability
    1-2 of 2
    on Behalf of IRIS Study Group
    Close
    Save search
    Follow your search
    Access your saved searches in your account
    Would you like to receive an alert when new items match your search?
    Close Modal
    Sort by
    Journal Articles

    Declining Rates of Adverse Events (AEs), Rare Occurrence of Serious AEs (SAEs), and No Unexpected Long-Term Side Effects at 5 Years in Patients with Newly Diagnosed Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) Initially Treated with Imatinib (IM) in the International Randomized Study of Interferon vs STI571 (IRIS).

    Hagop M. Kantarjian, MD, Richard A. Larson, MD, Francois Guilhot, MD, Stephen G. O’Brien, MBChB, PhD, Brian J. Druker, MD, on Behalf of IRIS Study Group
    Journal: Blood
    Blood (2006) 108 (11): 2136.
    https://doi.org/10.1182/blood.V108.11.2136.2136
    Published: 2006
    Journal Articles

    Patients with Chronic Phase CML in the IRIS Study Who Receive Imatinib Mesylate (IM) 2 nd Line after Prior IFN/Ara-C Have Sustained Complete Cytogenetic and Major Molecular Response Rates Similar to 1 st Line IM Patients.

    Jaspal Kaeda, Andreas Hochhaus, Jerald Radich, Susan Branford, Charlene So, Insa Gathmann, Elisabeth Wehrle, John Goldman, Timothy Hughes, on Behalf of IRIS Study Group
    Journal: Blood
    Blood (2006) 108 (11): 2139.
    https://doi.org/10.1182/blood.V108.11.2139.2139
    Published: 2006

    Advertisement intended for health care professionals

    Email alerts

    First Edition Alert
    Latest Issue Alert
    Close Modal

    Advertisement intended for health care professionals

    Blood
    • Current Issue
    • First edition
    • All Issues
    • Collections
    • Abstracts
    • Authors
    • Submit to Blood
    • About Blood
    • Subscriptions
    • Public Access
    • Permissions
    • Alerts
    • Contact Us
    • Newsroom
    • Blood Classifieds
    • Advertising in Blood
    • Terms and Conditions
    • Twitter
    • American Society of Hematology
    • 2021 L Street NW, Suite 900
    • Washington, DC 20036
    • TEL +1 202-776-0544
    • FAX +1 202-776-0545
    American Society of Hematology

    ASH Publications

    • Blood
    • Blood Advances
    • Blood Global Hematology
    • Blood Neoplasia
    • Blood Vessels, Thrombosis & Hemostasis
    • Hematology, ASH Education Program
    • ASH Clinical News
    • ASH-SAP
    • The Hematologist

    American Society of Hematology

    • ASH Home
    • Research
    • Education
    • Advocacy
    • Meetings
    • Publications
    • ASH Store
    Copyright 2024 by American Society of Hematology
     
    • Cookie Settings
    • Privacy Policy
    • Cookie Policy
    • Terms of Use
    • Contact Us
    Close Modal
    Close Modal
    This Feature Is Available To Subscribers Only

    Sign In or Create an Account

    Close Modal
    Close Modal

    Advertisement intended for health care professionals